Journal of Peking University(Health Sciences) >
Clinical characteristics of central nervous system involvement in IgG4 related diseases
Received date: 2021-08-19
Online published: 2021-12-13
Supported by
National Natural Science Foundation of China(81971520)
Objective: To improve the understanding of the clinical characteristics of immunoglobulin G4-related disease (IgG4-RD) with central nervous system (CNS) involvement, so as to contribute to the early diagnosis and treatment. Methods: In this study, 10 patients with IgG4-RD with CNS involvement were selected. Clinical data including demographic features, clinical manifestations, organ involvement, laboratory findings, radiological results, pathology, treatments and outcomes were collected retrospectively. Results: Among the 10 IgG4-RD patients complicated with CNS involvement, 6 cases manifested as pituitary involvement and 4 cases manifested as dural involvement. Only 2 patients had nervous system involvement alone, while the left patients were complicated with other organ involvement besides nervous system. Half of the patients presented nervous system involvement as the initial manifestation, and the main symptoms of nervous system included polydipsia, polyuria, headache, decreased vision and so on. In the laboratory examination, the serum IgG4 level was increased in 9 cases (90.0%), and the total serum IgE was increased in 7 cases (87.5%). At the same time, their IgG, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were increased, while complement (C) 3 and C4 were decreased in some patients. Eight patients underwent tissue biopsies in different parts, the pathological examination showed a large number of lymphocyte and plasma cell infiltration, accompanied by fibrous tissue proliferation in part. All the patients were treated with glucocorticoids, and 8 cases (80%) were given immunosuppressants at the same time, and 3 cases were treated with rituximab when they expe-rienced disease relapse. As a result, 2 cases (20%) achieved complete remission (CR), and 8 cases (80%) achieved partial remission (PR). The median follow-up time was 13.5 months, and 4 cases relapsed. Conclusion: Pituitary and dura are common affected organs of IgG4-RD with CNS involvement. Most IgG4-RD patients with CNS involvement are combined with other organ involvement, but half of them presented nervous system involvement as the initial manifestation, and the symptoms are not typical. In order to make an early diagnosis, laboratory, imaging examination and tissue biopsy should be taken into consideration in combination if necessary.
Guang-yan MENG , Yun-xiao ZHANG , Yu-xin ZHANG , Yan-ying LIU . Clinical characteristics of central nervous system involvement in IgG4 related diseases[J]. Journal of Peking University(Health Sciences), 2021 , 53(6) : 1043 -1048 . DOI: 10.19723/j.issn.1671-167X.2021.06.006
| [1] | Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopatholo-gical entity of IgG4-related autoimmune disease[J]. J Gastroenterol, 2003, 38(10):982-984. |
| [2] | Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD[J]. Mod Rheumatol, 2021, 31(3):529-533. |
| [3] | Peng L, Zhang P, Zhang X, et al. Clinical features of immunoglobulin G4-related disease with central nervous system involvement: An analysis of 15 cases[J]. Clin Exp Rheumatol, 2020, 38(4):626-632. |
| [4] | Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease[J]. Lancet, 2015, 385(9976):1460-1471. |
| [5] | 王子乔, 刘燕鹰, 张霞, 等. 17例误诊为IgG4相关疾病患者的临床特点及误诊原因分析[J]. 北京大学学报(医学版), 2019, 51(6):1025-1031. |
| [6] | 朱星昀, 刘燕鹰, 孙学娟, 等. 免疫球蛋白G4相关疾病患者发病形式及就诊行为特征分析[J]. 北京大学学报(医学版), 2018, 50(6):1039-1043. |
| [7] | Iseda I, Hida K, Tone A, et al. Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis[J]. Endocr J, 2014, 61(2):195-203. |
| [8] | 李芊, 段炼, 李伟, 等. IgG4相关性垂体炎5例临床分析[J]. 中国实用内科杂志, 2018, 38(9):861-864. |
| [9] | Ohkubo Y, Sekido T, Takeshige K, et al. Occurrence of IgG4-related hypophysitis lacking IgG4-bearing plasma cell infiltration during steroid therapy[J]. Intern Med, 2014, 53(7):753-757. |
| [10] | Christakis PG, Machado DG, Fattahi P. Idiopathic hypertrophic pachymeningitis mimicking neurosarcoidosis[J]. Clin Neurol Neurosurg, 2012, 114(2):176-178. |
| [11] | 苏玉莹, 王晨琼, 董凌莉. IgG4相关性疾病的发病机制及进展[J]. 中华临床医师杂志:电子版, 2014(14):2713-2717. |
| [12] | 纪宗斐. IgG4相关性疾病(IgG4-RD)发病机制的研究进展[J]. 复旦学报(医学版), 2019, 46(1):114-118. |
| [13] | Leporati P, Landek-Salgado MA, Lupi I, et al. IgG4-related hypophysitis: A new addition to the hypophysitis spectrum[J]. J Clin Endocrinol Metab, 2011, 96(7):1971-1980. |
| [14] | Chan SK, Cheuk W, Chan KT, et al. IgG4-related sclerosing pachymeningitis: A previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease[J]. Am J Surg Pathol, 2009, 33(8):1249-1252. |
| [15] | Lee YS, Lee HW, Park KS, et al. Immunoglobulin G4-related hypertrophic pachymeningitis with skull involvement[J]. Brain Tumor Res Treat, 2014, 2(2):87-91. |
| [16] | Peng Y, Li JQ, Zhang PP, et al. Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: A long-term cohort study[J]. J Intern Med, 2019, 286(5):542-552. |
/
| 〈 |
|
〉 |